BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20124894)

  • 1. Balancing volume resuscitation and ascites management in cirrhosis.
    Polli F; Gattinoni L
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):151-8. PubMed ID: 20124894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamics and fluid retention in liver disease.
    Henriksen JH; Møller S
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):320-32. PubMed ID: 9759606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis.
    Henriksen JH
    Scand J Clin Lab Invest; 2004; 64(6):523-33. PubMed ID: 15370457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulatory dysfunction syndrome associated with liver cirrhosis].
    Hartleb M
    Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
    Schneditz D; Bachler I; Stadlbauer V; Stauber RE
    Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects.
    Møller S; Henriksen JH
    Semin Nephrol; 1997 Nov; 17(6):505-19. PubMed ID: 9353862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascites in cirrhosis: a review of management and complications.
    Kuiper JJ; van Buuren HR; de Man RA
    Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.